Search

everythinglearnresearchcommunity

for

Search:↓

The 675 nm laser treatment significantly increased hair density and reduced symptoms of androgenetic alopecia in both men and women, with no side effects.

Men with early onset hair loss are more likely to have high uric acid levels.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

Androgenetic Alopecia (AGA) greatly lowers quality of life, causing stress and low self-esteem, with those seeking treatment experiencing more impairment.

Hospital staff have a higher rate of hair loss than the general population.

Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.

FUE hair transplant is a promising method with benefits like less scarring, but requires a skilled surgeon and can damage hair follicles.

Phyllotex™ extract was found to significantly promote hair growth and protect against hair loss.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Identified genes linked to male-pattern baldness may help develop new treatments.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Trichoscopy is an effective, noninvasive method for early diagnosis of Female Pattern Hair Loss.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Baldness is linked to a higher risk of coronary artery disease, but not to its severity.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

People with androgenetic alopecia have a higher risk of heart disease.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

Americans see hair transplants as valuable for treating hair loss and want them to be more affordable and tailored to each gender.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

New understanding and treatments for hair loss are improving, but more research is needed.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Androgenetic alopecia is less common in Chilean Mapuche than Caucasians, but more common than Asians, with racial differences in prevalence and types.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.